SCHOLAR ROCK HOLDING CORPORATION Property, Plant and Equipment, Gross
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Property, Plant and Equipment, Gross of $16.58 million as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-03
- 2025-12-31: Property, Plant and Equipment, Gross $16.58M.
- 2024-12-31: Property, Plant and Equipment, Gross $15.98M.
- 2023-12-31: Property, Plant and Equipment, Gross $15.93M.
- 2022-12-31: Property, Plant and Equipment, Gross $17.61M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $16.58M 10-K · filed 2026-03-03 |
| 2024-12-31 | $15.98M 10-K · filed 2026-03-03 |
| 2023-12-31 | $15.93M 10-K · filed 2025-02-27 |
| 2022-12-31 | $17.61M 10-K · filed 2024-03-19 |
| 2021-12-31 | $16.86M 10-K · filed 2023-03-07 |
| 2020-12-31 | $12.98M 10-K · filed 2022-03-07 |
| 2019-12-31 | $7.73M 10-K · filed 2021-03-09 |
| 2018-12-31 | $5.55M 10-K · filed 2020-03-12 |
| 2018-09-30 | $4.74M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $3.76M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $3.73M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |